Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication

Background. We tested the hypotheses that the addition of medication to psychotherapy enhances participation in the latter by: (1) speeding the acquisition of the psychotherapy's targeted skill; and (2) facilitating higher skill level acquisition. Method. Participants were 431 chronically depressed patients who received Cognitive Behavioral Analysis System of Psychotherapy (CBASP), alone (N=214) or in combination with nefazodone (N=217), as part of a randomized chronic depression study (Keller et al. 2000). CBASP, developed specifically to treat chronic depression, uses a specific procedure, ‘situational analysis’ to help patients engage in more effective goal-oriented interpersonal behaviours. At the end of each session, therapists rated patients on their performance of situational analysis. Outcome on depressive symptoms was assessed with the 24-item Hamilton Rating Scale for Depression. Results. Although reductions in depression were significantly greater in combined treatment compared to CBASP alone, there were no between-group differences in either the rate of skill acquisition or overall skill level at the end of treatment. Proficiency in the use of the main skill taught in psychotherapy at treatment midpoint predicted outcome independently of medication status and of baseline depressive severity. Conclusions. Effective participation in CBASP, as reflected by proficiency in the compensatory skill taught in psychotherapy, is not enhanced by the addition of medication and does not mediate the between-group difference in depression outcome.

[1]  H. Conte,et al.  Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence. , 1986, Archives of general psychiatry.

[2]  A. Rush,et al.  The role of psychotherapy in the treatment of depression: review of two practice guidelines. , 1996, Archives of general psychiatry.

[3]  S. Hollon,et al.  Differential effects of cognitive therapy and pharmacotherapy on depressive symptoms. , 1981, Journal of affective disorders.

[4]  Larry E. Toothaker,et al.  Multiple Regression: Testing and Interpreting Interactions , 1991 .

[5]  J. Dekker,et al.  Combining psychotherapy and antidepressants in the treatment of depression. , 2001, Journal of affective disorders.

[6]  M. Thase,et al.  Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy. , 1996, Archives of general psychiatry.

[7]  W M Grove,et al.  How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression. , 1990, Journal of consulting and clinical psychology.

[8]  M. Shea,et al.  Mode-specific effects among three treatments for depression. , 1990, Journal of consulting and clinical psychology.

[9]  J. Claiborn Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy , 2001 .

[10]  M. Weissman,et al.  Medication and psychotherapy. , 1994 .

[11]  A. Rush,et al.  Compliance With Pharmacotherapy in Mood Disorders , 1995 .

[12]  A. Rush Treatment of major depression , 1993 .

[13]  D J Kupfer,et al.  Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. , 1997, Archives of general psychiatry.

[14]  Ellen L. Lewis,et al.  Facilitating Treatment Adherence: A Practitioner’s Guidebook , 1989 .

[15]  A. Simons,et al.  Predicting response to cognitive therapy of depression: The role of learned resourcefulness , 1985, Cognitive Therapy and Research.

[16]  J. Markowitz,et al.  A review of combined psychotherapy and pharmacotherapy in the treatment of depression. , 1992, The Journal of psychotherapy practice and research.

[17]  H. Kraemer,et al.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. , 2001, The American journal of psychiatry.

[18]  J. Fawcett,et al.  Clinical management--imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. , 1987, Psychopharmacology bulletin.

[19]  M. Thase,et al.  Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients. , 1996, American Journal of Psychiatry.

[20]  A. Simons,et al.  The process of change in cognitive therapy and pharmacotherapy for depression. Changes in mood and cognition. , 1984, Archives of general psychiatry.

[21]  A. Simons,et al.  The Process of Change in Cognitive Therapy and Pharmacotherapy for Depression , 1984 .

[22]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[23]  J. Markowitz,et al.  A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. , 2000, The New England journal of medicine.

[24]  Daniel J Buysse,et al.  Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles. , 1997, The American journal of psychiatry.

[25]  I. Blackburn,et al.  Changes in Cognition with Pharmacotherapy and Cognitive Therapy , 1983, British Journal of Psychiatry.